Home > Inhibitors & Agonists
Cat. No. Product name CAS No.
DCC2393 Gsk4028

Negative control for GSK4027

2079886-19-2
DCC2394 Gsk41364a

Novel specific inhibitor of polo-like kinase 1 (PLK-1), inducing cell death by causing cell cycle arrest at G2/M phase by competing with the ATP binding site of PLK-1 thus leading to apoptosis

DCC2395 Gsk452

Novel, Potent, Selective, and Highly Soluble Bromo and Extraterminal Domain (BET) Second Bromodomain (BD2) Inhibitor

DCC2396 Gsk466317a

Novel selective inhibitor of G protein-coupled receptor kinase 2 (GRK2)

864082-48-4
DCC2397 Gsk557296

Novel highly potent and selective non-peptide oxytocin receptor antagonist

872599-83-2
DCC2398 Gsk572a

Novel potent EchA6 inhibitor

1403602-32-3
DCC2399 Gsk5750

Novel inhibitor of the Ribonuclease H Activity of HIV-1 Reverse Transcriptase

1312345-89-3
DCC2400 Gsk579289a

Potent polo-like kinase 1 (PLK1) inhibitor

929095-23-8
DCC2401 Gsk635416a

Novel ATM inhibitor with cancer cell specific radiosensitization activity

944729-29-7
DCC2402 Gsk6776

Novel, soluble, permeable, and selective BRD7/9 inhibitor

DCC2403 Gsk699

Novel PCAF/GCN5 degrader, modulating PCAF/GCN5 immune cell function through a PROTAC approach

2260944-68-9
DCC2404 Gsk702

Negative control for GSK699

DCC2405 Gsk716

Novel stabilizer of Zα 1 -antitrypsin, blocking Zα 1 -antitrypsin polymerisation in vitro, reducing intracellular polymerisation and increasing the secretion of Zα 1 -antitrypsin threefold in an iPSC model of disease

DCC2406 Gsk729

Novel potent inhibitor of EchA6

1403602-92-5
DCC2407 Gsk-756619

Novel Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitor

DCC2408 Gsk791

Negative control for GSK789

DCC2409 Gsk809

Novel potent and selective BET pan-BD2 inhibitor

DCC2410 Gsk8470

Novel agonist of the orphan nuclear receptors steroidogenic factor-1 (SF-1, NR5A1) and liver receptor homologue-1 (LRH-1, NR5A2)

1276664-65-3
DCC2411 Gsk866

Selective glucocorticoid receptor agonist (SEGRA)

960248-81-1
DCC2412 Gsk8815

Negative control for GSK8814

DCC2413 Gsk926

Highly potent, selective, SAM-competitive, and cell-active EZH2 inhibitor

1346704-13-9
DCC2414 Gsk932121

Antimalarial

958457-44-8
DCC2415 Gsk943

Negative control for GSK073

DCC2416 Gsk-943949a

Novel potent protein kinase C-related kinase 1 (PRK1) inhibitor with IC50 of 40±8.7 nM)

DCC2417 Gsk945237

Novel potent inhibitor of bacterial type IIA topoisomerases

944406-54-6
DCC2418 gsk966

Selective inhibitor of iE-DAP-stimulated IL-8 release via the NOD1 signaling pathway

898466-31-4
DCC2419 Gsk966587

Potent inhibitor of bacterial type IIA topoisomerases

DCC2420 Gsk9772

Novel potent transrepression-selective liver X receptor modulator with anti-inflammatory activity

928035-84-1
DCC2421 Gsk990

Negative control as an inactive IDH1 inhibitor

1816331-64-2
DCC2422 Gsm-10h

Next-generation NSAID-like γ-secretase modulator (GSM) with improved in vitro potency and brain penetration, effectively lowering Aβ42 production in cells and in amyloid precursor protein transgenic mice

DCC2423 Gst-hg-121

Novel hepatitis B surface antigen (HBsAg) inhibitor for the treatment of hepatitis B virus infection

DCC2424 Gt-2331

Novel potent histamine H3 receptor antagonist

213027-19-1
DCC2425 Gtpl10720

Novel broad-spectrum inhibitor of coronavirus and enterovirus replication, targeting the main protease (Mpro or 3CLpro)

DCC2426 Gtpl11148

First-In-Class Antagonist against the Adrenomedullin-2 (AM2) Receptor

DCC2427 Guanoxyfen Sulfate

Inhibitor of vasoconstrictor responses to sympathetic nerve stimulation, potentiating the actions of adrenaline and noradrenaline, increasing the blood glucose concentration and decreasing the appetite

1021-11-0
DCC2428 Guggulsterone-52

Novel inhibitor of the activation of nuclear factor (NF)-κB signaling in bone marrow-derived dendritic cells, significantly inhibiting LPS-induced IL-12p40 and TNF-α gene expression, IκBα degradation, and NF-κB DNA binding activity in BMDCs, attenuating c

DCC2429 Guineesine

Acyl-CoA, inhibiting cholesterol acyltransferase

55038-30-7
DCC2430 Gummadiol

Natural inhibitor of 3C-like protease (3CLpro), targeting SARS-CoV-2 3CLpro, SARS-CoV 3CLpro and MERS-CoV 3CLpro

DCC2431 Gv2-20

Potent inhibitor of cabonic anhydrase 2 (CA2)

346411-65-2
DCC2432 Gw 791343 Hydrochloride

Negative allosteric modulator of human P2X7 and a positive allosteric modulator of rat P2X7

1019779-04-4
DCC2433 gw0072

Potent inhibitor of adipocyte differentiation and weak partial agonist of

321557-86-2
DCC2434 Gw012x

Novel Selective and Nonpeptidomimetic Proteasome Inhibitor As an Antimalarial, specifically inhibiting the proteasome activity in P. falciparum

DCC2435 gw0791

Novel agonist for retinoid X receptor

503620-39-1
DCC2436 Gw297361x

Inhibotor of active Vaccinia-Related Kinases (VRK)

1644443-93-5
DCC2437 Gw305178x

Novel inhibitor of CDK

748124-64-3
DCC2438 Gw3333

Novel selective and soluble inhibitor of tumor necrosis factor-alpha converting enzyme (TACE)

212609-68-2
DCC2439 gw409544

Potent and selective full agonist for peroixisome proliferator-activated receptor-alpha

258345-41-4
DCC2440 Gw440139a

Novel potent RET kinase inhibitor

DCC2441 gw441756 Hydrochloride

Potent TrkA kinase inhibitor

1049740-77-3
DCC2442 Gw493838

Novel agonist at the adenosine A1 receptor

253124-46-8
DCC2443 gw5638

Orally active, nonsteroidal tamoxifen derivative and a ligand for the estrogen receptors (ERs), steroid receptor members of the nuclear receptor superfamily of transcription factors

155701-61-4
DCC2444 Gw568377a

Inhibitor of Mer Kinase, also inhibiting EGFR

231277-83-1
DCC2445 Gw612286x

Novel VEGFR inhibitor, also a moderate inhibitor of BET proteins with an IC 50 value of 4.6 μM for BRD4(1)

DCC2446 Gw648495

Potent inhibitor of PfDHODH, showing greater than 4,000-fold selectivity for the malarial enzyme

92872-51-0
DCC2447 gw693881a

Novel inhibitor of EGFR

1135150-72-9
DCC2448 Gw701427a

Novel inhibitor of firefly luciferase derived from Photinus pyralis (FLuc), the most widely used luciferase

DCC2449 Gw780056x

Selective cyclin dependent kinase inhibitor; Inhibitor of Yes1 kinase; Inhibitor of binding or entry into cells for Lassa Virus

1093294-48-4
DCC2450 gw7845

Selective agonist of peroxisome proliferator-activated receptor-γ (PPARγ)

196809-22-0
DCC2451 Gw807982x

Potent and selective inhibitor of glycogen synthase kinase 3 (GSK3)

DCC2452 Gw809897x

Novel and potent inhibitor of VEGFR2 tyrosine kinase, non-selectivey inhibiting AURKA and AURKB

DCC2453 Gw827106x

Potent GSK-3 inhibitor, highly selective over CDK-2

681432-07-5
DCC2454 Gw833373x

Novel Inhibitor of GSK3beta

681432-85-9
DCC2455 Gw837016x

Novel inhibitor of mitosis and cytokinesis in T. brucei which causes human African trypanosomiasis (HAT)

833473-68-0
DCC2456 Gw844520

Novel potent and selective inhibitor of the cytochrome bc1 complex of mitochondrial electron transport in P. falciparum

137735-25-2
DCC2457 gw853606

Novel polo-like kinase (PLK1) inhibitor

660869-54-5
DCC2458 Gw856804x

Novel NAD+-competitive Sirt2 inhibitor

DCC2459 Gwl-78

Novel modulator of NF-Y transcription, inhibiting the binding of NF-Y to DNA, blocking cellular proliferation and cell cycle progression, interacting with a variety of CCAAT-containing promoters leading to p53-independent cell cycle arrest

DCC2460 Gx-395

Novel inhibitor of Nav1.7

1235403-87-8
DCC2461 Gx-585

Novel potent inhibitor of NaV1.7 and highly selective against NaV1.5, having limited selectivity against NaV1.1 and NaV1.2

DCC2462 Gx-629

GX-936 analog, antagonist of voltage-gated sodium 1.7 (Nav1.7) channels

DCC2463 Gyki-53655

AMPA antagonist

143692-18-6
DCC2464 Gyramide A

Novel bacterial DNA gyrase inhibitor, exhibiting antimicrobial activity and inhibiting bacterial cell division

913509-94-1
DCC2465 H-0104 Dihydrochloride

Novel Rho-associated coiled coil-formed protein kinase (ROCK) inhibitor, exerting strong intraocular pressure (IOP)-lowering effects into the eyes of monkeys

913636-88-1
DCC2466 H-0106 Dihydrochloride

Novel Rho-associated coiled coil-formed protein kinase (ROCK) inhibitor, exerting strong intraocular pressure (IOP)-lowering effects into the eyes of monkeys

1011465-90-9
DCC2467 h1-agonist-39

Novel full H1 agonist

162049-83-4
DCC2468 H2-003

Novel class of selective diacylglycerol acyltransferase 2 (DGAT2) inhibitor

1060438-30-3
DCC2469 H2-005

Novel class of selective diacylglycerol acyltransferase 2 (DGAT2) inhibitor

1060478-12-7
DCC2470 H2a-4t

Novel water-soluble and biocompatible small-molecule near-infrared II (NIR-II) fluorescent dye

DCC2471 h2lassbio-1064

Inhibitor of acetic acid-induced writhing response

125741-50-6
DCC2472 H-4073

Novel inhibitor of STAT3 activation, inhibiting head and neck cancer cell proliferation in a dose dependent manner

DCC2473 H77-77

Inhibitor of monoamine oxidase (MAO)

21618-99-5
DCC2474 Ha Protein Inhibitor 1

Novel hemagglutinin (HA) protein inhibitor, inhibiting entry and replication of diverse influenza viruses via the HA protein, showing potent antiviral activity against diverse H1N1, H5N1, and H3N2 influenza viruses encoding HA proteins from both groups 1

346715-10-4
DCC2475 Halauxifen

Herbicide, being used for the control of broad-leaved weeds in cereals and oilseed rape

943832-60-8
DCC2476 Halobetasol

Topical corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictor activities, inducing phospholipase A2 inhibitory proteins, activating gene expression of anti-inflammatory proteins mediated via the corticosteroid receptor response element

98651-66-2
DCC2477 Halofantrine Hydrochloride

Antimalarial, binding to plasmpesin, a haemoglobin degrading enzyme unique to the malarial parasites

36167-63-2
DCC2478 Halofenate

Selective peroxisome proliferator-activated receptor gamma (PPAR-gamma) modulator with antilipidemic activity

26718-25-2
DCC2479 Haloprotac2

Novel HaloPROTAC degrader, inducing degradation of HaloTag fusion proteins

1799506-06-1
DCC2480 Haloquinone

Novel Wnt inhibitor, blocking Wnt signaling downstream of beta-Catenin

80902-01-8
DCC2481 Haploscleridamine

Novel inhibitor of cathepsin K (CatK)

DCC2482 Haptamide B

Novel selective inhibitor of Hap2/3/4/5p mediated transcription in vivo.

546124-87-2
DCC2483 Harringtonolide

Natural antiproliferative, antifungal, antitumor agent, suppressing the epithelial-mesenchymal transition (EMT) process and inhibiting activation of the FAK/Src/STAT3 signaling pathway in A375 cells, targeting RACK1 to suppress cancer cell migration

64761-48-4
DCC2484 hat Inhibitor C107

Novel p300/CBP HAT inhibitor

1417741-58-2
DCC2485 Hatric

Precursor for HATRIC-based ligand receptor capture (HATRIC-LRC)

DCC2486 Hbf-0079

Hepatocellular carcinoma (HCC)-selective cytotoxin, suppressing AKT anti-apoptotic signaling

315702-93-3
DCC2487 Hc102a

Novel Inhibitor of Mycobacterium tuberculosis DosRST signaling and persistence

91216-38-5
DCC2488 Hc103a

Novel Inhibitor of Mycobacterium tuberculosis DosRST signaling and persistence

312595-37-2
DCC2489 Hc104a

Novel inhibitor of DosRST, inhibiting DosR DNA binding in a dose-dependent manner by directly targeting DosR

DCC2490 Hc106a

Novel inhibitor of DosRST, inhibiting Mtb survival during hypoxia-induced NRP, directly targeting the sensor kinase heme, via a mechanism that is distinct from the oxidation and alkylation of heme previously observed with artemisinin (HC101A)

DCC2491 Hca Xii-in-2c

Novel inhibitor of human carbonic anhydrase XII (hCA-XII), demonstrating significant antiproliferative activity against hypoxic tumor cell lines

DCC2492 Hca-ix/xii-in-4m

Novel selective dual carbonic anhydrase IX and XII inhibitor

DCC2493 Hci-2184

Novel Nek2 inhibitor, successfully mitigating drug resistance in bortezomib-resistant multiple myeloma; Potent AXL kinase inhibitor

1341200-61-0
DCC2494 Hcov-in-8n

Novel inhibitor of human coronavirus 229E (hCoV 229E) replication with an EC50 value of 5.5 µM

DCC2495 HCT1026

Selective modulator of amyloid-beta peptide degradation, regulating Abeta levels.

158836-71-6
DCC2496 Hct-13

Novel copper-dependent cytotoxic agent, being highly potent against a panel of pancreatic, small cell lung carcinoma, prostate cancer, and leukemia models, with IC50 values in the low-to-mid nanomolar range

DCC2497 Hcv Gt2a Inhibitor 5m

Antiviral agent against HCV genotype 2a JFH-1 infected in human Huh7.5.1 cells

DCC2498 Hcv-in-5

Novel Inhibitor of Hepatitis C Virus

491586-35-7
DCC2499 Hd-800

High affinity and selective colchicine site tubuline inhibitor amenable to radiolabel with C-11, a positron emitting isotope

DCC2500 Hdac6 Degrader 14a

Novel PROTAC HDAC6 degrader, efficiently and selectively decreased HDAC6 levels in several cell lines, including activated THP-1 cells

DCC2501 Hdac6 Degrader Np8

Novel potent and selective PROTAC degrader of HDAC6 protein

DCC2502 Hdac6 Inhibitor 6h

Novel hHDAC6 inhibitor, having low inhibitory potency over hHDAC1 and hHDAC8, as potential pharmacological tools for idiopathic pulmonary fibrosis (IPF) treatment

DCC2503 Hdac6 Inhibitor Xp5

Novel potent HDAC6 inhibitor with an IC 50 of 31 nM and excellent HDAC6 selectivity (SI = 338 for HDAC6 over HDAC3), displaying high antiproliferative activity against various cancer cell lines including the HDACi-resistant YCC3/7 gastric cancer cells (IC

DCC2504 Hdac6-in-10c

Novel HDAC6 isoform-selective inhibitor, increasing the acetylation level of α-tubulin with little effect on the acetylation of histone H3, inducing apoptosis in HL-60 cell by activating caspase 3

DCC2505 Hdac6-in-3f

Potent and selective HDAC6 inhibitor

DCC2506 Hdac6-in-4b

Potent and selective HDAC6 inhibitor

DCC2507 Hdac6-in-w5

Novel highly potent and selective HDAC6 inhibitor with an IC 50 of 2.54 nM and being more than 290- to 3300-fold selective over other HDAC isoforms

DCC2508 Hdac8 Protac

First-in-class proteolysis targeting chimera (PROTAC) for selective degradation of histone deacetylase 8 (HDAC8)

DCC2509 Hdac8-in-8b

Novel Selective Histone Deacetylase 8 (HDAC8) Inhibitor with Anti-Neuroblastoma Activity

DCC2510 Hdac-in-6

Novel HDAC inhibitor, targeting HDAC2, HDAC3, HDAC4, HDAC5, HDAC7, HDAC8, and HDAC9

1026295-98-6
DCC2511 Hdac-in-h13

Novel Histone deacetylase (HDAC) inhibotor, displays potent inhibitory activity towards human HDACs and several cancer cells lines

DCC2512 Hdl376 Featured

HDL376 is a scavenger receptor class B type I (SR-BI) inhibitor. HDL376 directly inhibits SR-BI-mediated lipid transport in cells and in liposomes reconstituted with purified SR-BI (IC50 = 0.22 μM). HDL376 can be used for the research of atherosclerotic coronary artery disease.

147751-31-3
DCC2513 Hdp-mimic C4

Potent antifungal agent, hosting defense peptide mimic through a membrane-active mechanism

DCC2514 Hds029

Potent inhibitor of the ErbB receptor family (IC50 values are 0.3, 0.5 and 1.1 nM for ErbB1 (EGFR), ErbB4 and ErbB2 respectively)

881001-19-0
DCC2515 Helenalin Acetate

Anti-inflammatory and anti-cancer agent, disrupting the cooperation of CCAAT-box/enhancer-binding protein beta (C/EBPß) and co-activator p300

10180-86-6
DCC2516 Helenalin Methacrylate

Natural anti-inflammatory and anti-cancer agent

68798-43-6
DCC2517 Helioxanthin

Inhibitor of interleukin-1β-induced MIP-1β production

18920-47-3
DCC2518 Hemiasterlin

Cytotoxic peptide, inducing mitotic arrest and abnormal spindle formation

157207-90-4
DCC2519 Hemigossypol

The biosynthetic precursor of gossypol

40817-07-0
DCC2520 Hemisurfen

Heparan sulfate antagonist

46696-26-8
DCC2521 Heparin Disaccharide I-s Sodium Salt

Heparin derivative for treatment of thrombotic diseases

136098-10-7
DCC2522 Hepcidin

Master regulator of iron homeostasis, contributing to Swedish mutant APP-induced osteoclastogenesis and trabecular bone loss

1356390-47-0
DCC2523 Hepta-histidine

Novel inhibitor of Tau aggregation against Tau-related neurodegenerative diseases including Alzheimer's disease (AD)

64134-31-2
DCC2524 Het-dpd-13a

Novel LsrK inhibitor (ID 50 119 μM) agaist antimicrobial resistance (AMR)

DCC2525 Heterotaxin

Novel TGF-β Signaling Inhibitor

886862-25-5
DCC2526 Hetrombopag Olamine

Novel orally bioavailable, non-peptide thrombopoietin (TPO) receptor agonist

1257792-42-9
DCC2527 Hexafluoro

Novel inhibitor of the phosphorylation of DRP1, stimulating a phenotype suggestive of respiration through mitochondrial normalization and demonstrating activity in Vemurafenib-resistant melanoma in vivo

128481-73-2
DCC2528 Hexim1 Inducer 4a1

Novel potent inducer of hexamethylene bis-acetamide inducible protein 1 (HEXIM1)

DCC2529 Hexyl-acrdim

Potent inducer of oxidative stress as well as cell cycle arrest in the S-phase, significantly decreasing intracellular ATP level

DCC2530 Hfi-142

Insulin-regulated aminopeptidase (IRAP) inhibitor, mprovin memory in control and memory-deficient mice models

332164-34-8
DCC2531 Hg-7-85-01

Novel type II inhibitor of wild-type and gatekeeper mutants of BCR-ABL, PDGFRalpha, Kit, and Src kinases

1258391-13-7
DCC2532 Hgh Fragment 177-191 (tfa Salt)

Fragment 177-191 of human growth hormone, regulating fat metabolism but without the adverse effects on blood sugar or growth, stimulating lipolysis (the breakdown or destruction of fat) and inhibiting lipogenesis (the transformation of nonfat food materia

66004-58-8
DCC2533 Hhs-465

Novel sulfur-triazole exchange (SuTEx) covalent probe with ~5-fold enhanced chemoselectivity for tyrosines over other nucleophilic amino acids

DCC2534 Clomethiazole Edisylate

Positive allosteric modulator at the barbiturate/picrotoxin site of the GABAA receptor

1867-58-9
DCC2535 Hi-207

Non-nucleoside reverse transcriptase inhibitor

244268-79-9
DCC2536 Hi-253

Potent non-nucleoside inhibitor of drug-resistant human immunodeficiency virus (HIV)

DCC2537 Hi-346

Potent inhibitor of multidrug-resistant human immunodeficiency virus-1 (HIV-1)

149486-68-0
DCC2538 Hiapp(22-27)

Hexapeptide sequences of hIAPP, being sufficient for the formation of beta-sheet-containing amyloid fibrils and coiling around each other in a typical amyloid fibril morphology

121341-41-1
DCC2539 Hiapp(23-27)

Pentapeptide sequences of hIAPP, being sufficient for the formation of beta-sheet-containing amyloid fibrils and self-assemble laterally into unusually broad ribbons

DCC2540 Hie-124

CNS active anticonvulsant and ultra-short acting hypnotic

805326-00-5
DCC2541 Hif-1alpha Inhibitor-1

Novel HIF-1alpha inhibitor

1000025-14-8
DCC2542 Hif-1alpha-p300 Ppi Inhibitor-3

Novel HIF-1alpha-p300 Protein Protein Interaction inhibitor

DCC2543 Hif-hydroxylase Modulator

Novel hypoxia inducible factor hydroxylase modulator

909010-67-9
DCC2544 Hif-hydroxylase Modulator-ii

Novel hypoxia inducible factor hydroxylase modulator

952397-50-1
DCC2545 Hif-in-33

Novel HIF Pathway Inhibitor

1085450-53-8
DCC2546 Himbacine

Natural muscarinic receptor antagonist

6879-74-9
DCC2547 Hipk1/2-in-a64

Novel Potent Inhibitor of HIPK1/HIPK2 Kinase

DCC2548 Hippeastrine Hydrobromide

Natural alkaloid, demonstrating significant cytotoxicity against a panel of human and murine tumor cell lines

22352-41-6
DCC2549 Histidine-proline

Allosteric inhibitor of ATP phosphoribosyltransferase (ATPPRT), binding to the ATPPRT:ATP complex via a two-step binding mechanism, inhibiting ATPPRT competitively and likely uncompetitively, respectively, against PRPP and ATP

20930-58-9
DCC2550 Histidyl-histidine

Novel enhancer of catalytic efficiency of neurolysin

306-14-9
DCC2551 Histidyltyrosine

Novel enhancer of catalytic efficiency of neurolysin

35979-00-1
DCC2552 Hiv-1 In Photoprobe

Novel photoaffinity-labeled probe for full-length human immunodeficiency virus-1 integrase (HIV-1 IN)

DCC2553 Hiv-1 Inhibitor 9d

Novel highly potent HIV-1 inhibitor with broad-spectrum activity (EC50 = 2.0-57 nM) against resistant strains, exhibiting good solubility and safety profiles and a good PK profile with an oral bioavailability of 59% in rats

DCC2554 hjc0122

AMPA Receptor Positive Allosteric Modulator

1453096-68-8
DCC2555 Hjc0123

Novel orally bioavailable STAT3 inhibitor

1430420-02-2
DCC2556 Hjc0149

Novel potent orally bioavailable inhibitor of signal transducer and activator of transcription 3 (STAT3)

1430330-65-6
DCC2557 Hjc05100

Novel apigenin analogue, suppressing pancreatic stellate cell proliferation

1612891-85-6
DCC2558 Hk Inhibitor 2

Novel inhibitor of YycG histidine kinase (HK), showing potent antibiofim activity against Staphylococcus epidermidis

352683-04-6
DCC2559 Hk2 Modulator-1

Novel allosteric hexokinase 2 (HK2) modulator, selectively detaching HK2 from the mitochondria

DCC2560 hl010183

Novel Metformin Derivative; Inhibitor of Proliferation and Invasion of Triple-Negative Breast Cancer Cells

1125365-14-1
DCC2561 Hl-3-68

Novel SARS-CoV-2 Main Protease (Mpro) inhibitor, binding to Subsites S1 and S2 (K d =0.69 µM)

DCC2562 hla20a

Selective Acetylcholinesterase Inhibitor

1162140-23-9
DCC2563 Hlb-0532247

Novel phosphoramidate prodrug of ddhCTP, effectively reducing titers of Zika and West Nile viruses in cell culture with minimal nonspecific toxicity to host cells

DCC2564 Hlcl-61

First-in-class inhibitor of protein arginine methyltransferase 5 (PRMT5)

586395-74-6
DCC2565 Hlö-7 Dimesylate

Novel Nerve Agent Reactivator

DCC2566 Hm-50316

Potent and highly selective FABP4 inhibitor

1310361-52-4
DCC2567 Hm90822

Novel antagonist to the inhibitors of apoptosis (IAPs), potentiating cell death in EGFR-overexpressing non-small-cell lung cancer cells

DCC2568 Hmao-b Inhibitor 5

Novel highly potent, selective, and competitive hMAO-B inhibitor with high BBB permeability profile and neuroprotective action (IC 50 = 42 nM; SI > 2375)

DCC2569 Hmbpp Triammonium Salt

Potent stimulator of gamma delta T cells

443892-56-6
DCC2570 Hmi-1a3

Protein kinase C partial agonist, targeting the C1 domain, inhibiting cell proliferation, decreasing cell viability and inducing an apoptotic response

DCC2571 Hmk-32

Irriversible inhibitor of GSK3

DCC2572 Hm-mc4-ppea

Potent inhibitor of nicotinamide phosphoribosyltransferase (Nampt)

DCC2573 Hmr1031

Potent and specific integrin α4ß1 or very late antigen 4 (VLA-4) receptor antagonist, binding to vascular cell adhesion molecule-1 (VCAM-1) and fibronectin

479203-71-9
DCC2574 Hmr1426

Novel food intake-reducing agent

262376-75-0
DCC2575 Hmr-1566

Potent and selective I ks channel blocker

223749-45-9
DCC2576 Hmref-s-neu5ac

Novel sialidase-activatable fluorescence probe with improved stability for the sensitive detection of sialidase

DCC2577 Hmref-ßglcnac

Novel Hexosaminidase-Targeting Fluorescence Probe for Visualizing Human Colorectal Cancer.

DCC2578 Hms-i1

Novel chemical probe for heterochromatin formation and function, disrupting of heterochromatin-mediated transcriptional gene silencing

702636-92-8
DCC2579 Hms-i2

Novel chemical probe for heterochromatin formation and function, disrupting of heterochromatin-mediated transcriptional gene silencing

690626-60-9
DCC2580 Hmsir-tubulin

Novel Blinking Fluorescent Probe for Tubulin Nanoscopy in Living and Fixed Cells

DCC2581 Hn-cbl

Novel selective inhibitor of the lymphocytic leukemia (LL) cell survival , Selectively Enhancing the Killing Effect through STAT3 Binding on Lymphocytic Leukemia Cells In Vitro and In Vivo

DCC2582 Hnpc-a3066

Novel strobilurin acaricide, exhibiting larvicidal and ovicidal activities against various acarids

DCC2583 Hocpca

Highly potent and selective ligand for the GHB binding sites, binding with 27 times better affinity than GHB itself and acrossing the blood brain barrier in vitro and in vivo

867178-11-8
DCC2584 Hoechst-3325

Fluorescent indicator of apoptosis, binding the minor groove of DNA at A and T rich regions

23491-44-3
DCC2585 Hoi-07

Novel specific Aurora B inhibitor

1606160-40-0
DCC2586 Holomycin

Antibiotic

488-04-0
DCC2587 Holothurin A

Natural inhibitor of dietary fat absorption and showing strong anti-obesity activity

38-26-6
DCC2588 Homochlorcyclizine Dihydrochloride

Histamine H1 receptor antagonist

1982-36-1
DCC2589 Homovanillyl Sinapate

Novel c-Met inhibitor, markedly reducing tumor growth, showing excellent pharmacodynamics, and suppressing cell proliferation and microvessel density in an orthotopic model of triple negative breast cancer

DCC2590 Hpta-1

Novel highly selective switch-on fluorescence sensor, targeting telomeric dimeric G-quadruplex, discriminating the telomeric dimeric G-quadruplex TTA45 against other types of DNA structures accompanied by a drastic enhancement of the emission intensity wi

DCC2591 Hpxr-agonist-28

Novel silanol-based human pregnane X receptor (PXR) agonist

DCC2592 Hr1405-01

Loxoprofen active metabolite, acting as a safe intravenous NSAID with superior anti-inflammatory and analgesic activities

83648-76-4
<Prev1...164165166167168...191Next>